Sign in

CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
850642577
Phone
650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 10-K Report Annual Report
  2. 8-K Event Results of operations
  3. SC 13G Stake Amended Statement of Ownership
  4. 4 Option exercise Chief Financial Officer acquired 15,000 shares (option exercise)
  5. 4 Option exercise President & CEO acquired 24,154 shares (option exercise)
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 4 Grant or award VP, Finance and CAO acquired 50,000 shares (grant or award)
  8. 8-K Event Material agreement
  9. 424B5 Offering Prospectus
  10. 4 Option exercise Chief Medical Officer acquired 23,852 shares (option exercise)
  11. 4 Open-market sale Director sold 325,377 shares at an average $27.36 ($8,901,804)
  12. 4 Open-market sale 10% owner sold 48,390 shares at an average $26.61 ($1,287,431)
  13. 4 Open-market sale Director sold 145,637 shares at an average $32.26 ($4,698,091)
  14. 4 Open-market sale 10% owner sold 145,637 shares at an average $32.26 ($4,698,091)
  15. 4 Open-market sale Chief Medical Officer sold 14,884 shares at $36.77 ($547,314)
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 4 Open-market sale President & CEO sold 16,700 shares at an average $54.29 ($906,714)
  19. 4 Open-market sale President & CEO sold 16,700 shares at an average $54.29 ($906,714)
  20. 4 Open-market sale Chief Financial Officer sold 7,229 shares at an average $55.44 ($400,793)

Page 15 of 22 · 421 filings